75 related articles for article (PubMed ID: 3377855)
21. Pre- and co-treatment with xanthophyll enhances the anti-leukemic activity of adriamycin.
Lee KH
J Photochem Photobiol B; 2008 Sep; 92(3):175-9. PubMed ID: 18653355
[TBL] [Abstract][Full Text] [Related]
22. N-(5,5-diacetoxypentyl)doxorubicin: a novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells.
Zwelling LA; Altschuler E; Cherif A; Farquhar D
Cancer Res; 1991 Dec; 51(24):6704-7. PubMed ID: 1660346
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Trouet A; Sokal G
Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermia can differentially modulate the repair of doxorubicin-damaged DNA in normal and cancer cells.
Blasiak J; Widera K; Pertyński T
Acta Biochim Pol; 2003; 50(1):191-5. PubMed ID: 12673359
[TBL] [Abstract][Full Text] [Related]
25. Effect of sodium chloride concentration on adriamycin and N-trifluoroacetyladriamycin-14-valerate (AD32)-induced cell killing and DNA damage in Chinese hamster V79 cells.
Iliakis G; Lazar W
Cancer Res; 1987 Apr; 47(7):1853-8. PubMed ID: 3815376
[TBL] [Abstract][Full Text] [Related]
26. Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study.
Ragab AH; Sutow WW; Komp DM; Starling KA; Lyon GM; George S
Cancer; 1975 Oct; 36(4):1223-6. PubMed ID: 1058045
[TBL] [Abstract][Full Text] [Related]
27. Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients.
Watanabe N
Leuk Lymphoma; 1998 Aug; 30(5-6):477-82. PubMed ID: 9711910
[TBL] [Abstract][Full Text] [Related]
28. Impact of 1.8-GHz radiofrequency radiation (RFR) on DNA damage and repair induced by doxorubicin in human B-cell lymphoblastoid cells.
Zhijian C; Xiaoxue L; Yezhen L; Shijie C; Lifen J; Jianlin L; Deqiang L; Jiliang H
Mutat Res; 2010 Jan; 695(1-2):16-21. PubMed ID: 19833226
[TBL] [Abstract][Full Text] [Related]
29. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
30. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
Wiernik PH
Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
[No Abstract] [Full Text] [Related]
31. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II.
Potmesil M; Hsiang YH; Liu LF; Bank B; Grossberg H; Kirschenbaum S; Forlenza TJ; Penziner A; Kanganis D
Cancer Res; 1988 Jun; 48(12):3537-43. PubMed ID: 2836060
[TBL] [Abstract][Full Text] [Related]
32. Letter: Treatment of acute leukaemia.
Dubovsky D; Jacobs P
S Afr Med J; 1975 Nov; 49(46):1904. PubMed ID: 1198209
[No Abstract] [Full Text] [Related]
33. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of leukemia].
Hennemann HH
MMW Munch Med Wochenschr; 1976 Mar; 118(10):285-90. PubMed ID: 817149
[No Abstract] [Full Text] [Related]
35. [Adriamycin in the therapy of child leukemias and tumors].
Maas B; Ruhrmann G; Wilmanns W
Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):390-2. PubMed ID: 4356422
[No Abstract] [Full Text] [Related]
36. A precise pharmacodynamic study showing the advantage of a marked reduction in cardiotoxicity in continuous infusion of doxorubicin.
Ishisaka T; Kishi S; Okura K; Horikoshi M; Yamashita T; Mitsuke Y; Shimizu H; Ueda T
Leuk Lymphoma; 2006 Aug; 47(8):1599-607. PubMed ID: 16966272
[TBL] [Abstract][Full Text] [Related]
37. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
[TBL] [Abstract][Full Text] [Related]
38. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells.
El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH
DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797
[TBL] [Abstract][Full Text] [Related]
39. Adriamycin therapy in previously treated adult acute leukemia.
Wilson HE; Bodey GP; Moon TE; Amare M; Bottomley R; Haut A; Hewlett JS; Morrison F; Saiki JH
Cancer Treat Rep; 1977 Aug; 61(5):905-7. PubMed ID: 329985
[No Abstract] [Full Text] [Related]
40. Protection of human myeloid leukemic cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin 3.
Kaplinsky C; Lotem J; Sachs L
Leukemia; 1996 Mar; 10(3):460-5. PubMed ID: 8642862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
